Comments
Suven Life Sciences Ltd has secured four product patents, three from Australia and one from New Zealand, for its New Chemical Entities. The granted claims of the patents included the class of selective 5-HT compounds discovered by the Hyderabad-based company and being developed as therapeutic agents for treating cognitive impairment associated with neurodegenerative disorders, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.